% alzhub.org library filter % Source: https://alzhub.org/research?institution=I4210113058 % 8 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{jansen2015-25988462, author = {Jansen, W. J. and Ossenkoppele, R. and Knol, D. L. and Tijms, B. M. and Scheltens, P. and Verhey, F. R. and Visser, P. J. and {Amyloid Biomarker Study Group} and others}, title = {{Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis}}, journal = {JAMA}, year = {2015}, doi = {10.1001/jama.2015.4668}, pmid = {25988462}, url = {https://doi.org/10.1001/jama.2015.4668} } @article{ostrowitzki2022-36121669, author = {Ostrowitzki, S. and Bittner, T. and Sink, K. M. and Mackey, H. and Rabe, C. and Honig, L. S. and Cassetta, E. and Woodward, M. and others}, title = {{Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.2909}, pmid = {36121669}, url = {https://doi.org/10.1001/jamaneurol.2022.2909} } @article{bateman2023-37966285, author = {Bateman, R. J. and Smith, J. and Donohue, M. C. and Delmar, P. and Abbas, R. and Salloway, S. and Wojtowicz, J. and Blennow, K. and others}, title = {{Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease}}, journal = {The New England journal of medicine}, year = {2023}, doi = {10.1056/nejmoa2304430}, pmid = {37966285}, url = {https://doi.org/10.1056/nejmoa2304430} } @article{ostrowitzki2017-29221491, author = {Ostrowitzki, S. and Lasser, R. A. and Dorflinger, E. and Scheltens, P. and Barkhof, F. and Nikolcheva, T. and Ashford, E. and Retout, S. and others}, title = {{A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2017}, doi = {10.1186/s13195-017-0318-y}, pmid = {29221491}, url = {https://doi.org/10.1186/s13195-017-0318-y} } @article{salloway2025-39556389, author = {Salloway, S. and Wojtowicz, J. and Voyle, N. and Lane, C. A. and Klein, G. and Lyons, M. and Rossomanno, S. and Mazzo, F. and others}, title = {{Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease}}, journal = {JAMA neurology}, year = {2025}, doi = {10.1001/jamaneurol.2024.3937}, pmid = {39556389}, url = {https://doi.org/10.1001/jamaneurol.2024.3937} } @article{wagemann2024-38683602, author = {Wagemann, O. and Liu, H. and Wang, G. and Shi, X. and Bittner, T. and Scelsi, M. A. and Farlow, M. R. and Clifford, D. B. and others}, title = {{Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2024}, doi = {10.1001/jamaneurol.2024.0991}, pmid = {38683602}, url = {https://doi.org/10.1001/jamaneurol.2024.0991} } @article{jansen2018-29188296, author = {Jansen, W. J. and Ossenkoppele, R. and Tijms, B. M. and Fagan, A. M. and Hansson, O. and Klunk, W. E. and van der Flier, W. M. and Villemagne, V. L. and others}, title = {{Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia}}, journal = {JAMA psychiatry}, year = {2018}, doi = {10.1001/jamapsychiatry.2017.3391}, pmid = {29188296}, url = {https://doi.org/10.1001/jamapsychiatry.2017.3391} } @article{portron2020-31883703, author = {Portron, A. and Jordan, P. and Draper, K. and Muenzer, C. and Dickerson, D. and van Iersel, T. and Hofmann, C.}, title = {{A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers}}, journal = {Clinical therapeutics}, year = {2020}, doi = {10.1016/j.clinthera.2019.11.015}, pmid = {31883703}, url = {https://doi.org/10.1016/j.clinthera.2019.11.015} }